Risk of gestational diabetes mellitus in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis

Table 2 Meta-regression analysis coefficients of risk ratio of GDM

Variables	Coefficient (SE)	95% CI	Z	P
Publication year	−0.0028 (0.0108)	[− 0.0238, 0.0183]	−0.2557	0.800
N of cases	0.0004 (0.0002)	[<−0.0000, 0.0008]	1.8972	0.058
Age of cases	0.0034 (0.0078)	[−0.0120, 0.0187]	0.4334	0.665
aPL	−0.0066 (0.0063)	[−0.0190, 0.0057]	−1.0529	0.292
anti-ds-DNA	0.0022(0.0007)	[0.0008,0.0037]	3.0053	0.003*
Lupus nephritis	−0.0023 (0.0044)	[−0.0109, 0.0064]	− 0.5146	0.607
HCQ use	0.0021 (0.0011)	[<−0.0000, 0.0043]	1.9213	0.055
Glucocorticoids use	0.0024 (0.0008)	[0.0009, 0.0040]	3.0512	0.002*

aPL, antiphospholipid antibodies; anti-ds-DNA, anti-double stranded DNA antibodies; HCQ, hydroxychloroquine; CI, Confident interval; N, Number; SE, Standard error; *, P < 0.05

ISSN: 1471-2393